Brennan MF: Total parenteral nutrition in the cancer patient. N Engl J Med305:375, 1981
2.
Lister X.: Medical intelligence. N Engl J Med293:651, 1975
3.
Moloney TW, Rogers DE: Medical technology-a different view of the contentious debate over costs. N Engl J Med301:1413, 1979
4.
Knox RA: Heart transplants: to pay or not to pay. Science209:570, 1980
5.
Centerwall BS : Cost-benefit analysis and heart transplantation . N Engl J Med304:901, 1981
6.
Hiatt HH: Protecting the medical commons: who is responsible?N Engl J Med293:235, 1975
7.
Shepard DS, Thompson MS: First principles of cost-effectiveness in health. Public Health Rep94:535, 1979
8.
Weinstein MC , Statson WB: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med296:716, 1977
9.
Pauker SG, Kassirer JP: Therapeutic decision making: a costbenefit analysis. N Engl J Med293:229, 1975
10.
Barnes BA: Cost-benefit and cost-effective analysis in surgery. Surg Clin North Am62:737, 1982
11.
Bunker JP, Barnes BA, Mosteller F.: Costs, Risks, and Benefits of Surgery. Oxford University Press, New York, 1977
12.
Warner JE, Hutton RC: Cost-benefit and cost-effectiveness analysis in health care: growth and composition of the literature. Med Care28:1069, 1980
13.
Roberts D., Thelen D., Weinstein S.: Parenteral and enteral nutrition : a cost-benefit audit. Minn Medxx:707, 1982
14.
Koretz RL: Preoperative total parenteral nutrition in upper gastrointestinal cancer: how much for how much. Gastroenterology84(5 part 2): 1983 (abstr)
15.
Levey AS, Paker SG, Kassirer JP: Occult intracranial aneurysms in polycystic kidney disease: when is cerebral arteriography indicated?N Engl J Med308:986, 1983
16.
Landefeld JS , Seskin EP: The economic value of life: linking theory to practice. Am J Public Health72:555, 1982
17.
Mulley AG, Silverstein MD, Dienstag JL: Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis . N Engl J Med307:644, 1982
18.
Neuhauser D. , Lewicki AM: What do we gain from the sixth stool guaiac?N Engl J Med293:226, 1975
19.
Fuchs VR: What is CBA/CEA, and why are they doing this to us?N Engl J Med303:937, 1981
20.
Berwick DM, Komaroff AL: Cost-effectiveness of lead screening. N Engl J Med307:1270, 1982
21.
Finkler SA: The distinction between costs and charges. Ann Intern Med96:102, 1982
22.
Vanderveen TW, Robinson LA: Total parenteral nutrition solution preparation utilizing amino acid sources with and without pre-added electrolytes: a time and cost comparison, JPEN3:84, 1979
23.
Marty AT, et al: The variation in hospital charges: a problem in determining cost/benefit for cardiac surgery. Ann Thorac Surg24:409, 1977
24.
Wateska LP, Sattler LL, Steigher ER: Cost of a home parenteral nutrition program. JAMA244:2303, 1980
25.
Michel L., Serrano A., Malt RA: Nutritional support of hospitalized patients. N Engl J Med304:1147, 1981
26.
Kudsk KA, et al: Effect of enteral and parenteral feeding in malnourished rats with E. coli-hemoglobin adjuvant peritonitis. J Surg Res31:105-110, 1981
27.
Sako K., et al: Parenteral hyperalimentation in surgical patients with head and neck cancer: a randomized trial. J Surg Oncol16:391, 1981
28.
Brett AS: Hidden ethical issues in clinical decision analysis. N Engl J Med305:1150, 1981
29.
Freiman JA, et al: The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial: survey of 71 "negative" trials. N Engl J Med299:690, 1978
30.
Koretz RL: What supports nutritional support?Dig Dis Sci29:577-588, 1984
31.
Coquin JY, et al: Influence of parenteral nutrition on chemotherapy and survival of acute leukaemias; preliminary results of a randomized trial. JPEN4:437, 1980
32.
Shamberger RC, et al: The effect of total parenteral nutrition on chemotherapy-induced myelosuppression: a randomized study. Am J Med74:40, 1983
33.
Serrou XX, et al: Parenteral intravenous nutrition as an adjunct to chemotherapy in small cell anaplastic lung carcinoma. Cancer Treat Rep65(suppl 5):151, 1981
34.
Popp MB, et al: A prospective randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma : influence on survival. Surgery90:195, 1981
35.
Simms JM, Oliver E., Smith JAR: A study of total parenteral nutrition in major gastric and esophageal resection for neoplasia. JPEN4:422, 1980 (abstr)
36.
Müller JM, et al: Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet1:68, 1982
37.
Heatley RV, Williams RHP, Lewis MH: Preoperative intravenous feeding-a controlled trial. Postgrad Med J55:541, 1979
38.
Holter AR, Fischer JE: The effects of perioperative hyperalimentation on complications in patients with carcinoma and weight loss. J Surg Res23:31, 1977
39.
Jordan WM, et al: Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin and intensive IV hyperalimentation . Cancer Treat Rep65:197, 1981
40.
Thompson BR , Julian TB, Stremple JF: Perioperative total parenteral nutrition in patients with gastrointestinal cancer. J Surg Res30:497, 1981
41.
Valdivieso M., et al: Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma . Cancer Treat Rep65(suppl 5):145, 1981
42.
Issel BF, et al: Protection against chemotherapy toxicity by IV hyperalimentation . Cancer Treat Rep62:1139, 1978
43.
Serrou B., et al: Follow-up of a randomized trial for oat cell carcinoma evaluating the efficacy of peripheral intravenous nutrition as adjunct treatment. In Recent Results in Cancer Research, Vol 40. Springer-Verlag, Berlin, 1982, p 246
44.
Nixon DW, et al: Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep65(suppl 5);121, 1981
45.
Samuels ML, et al: IV hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep65:615, 1981
46.
Moghissi K. , et al: Parenteral nutrition in carcinoma of the esophagus treated by surgery: nitrogen balance and clinical studies. Br J Surg64:125, 1977
47.
Remington RD , Schorla MA: Statistics with Applications to the Biological and Health Sciences. Prentice-Hall, Englewood Cliffs, NJ, 1970
48.
Statistical Abstract of the United States-1982-83. U.S. Government Printing Office, Washington, DC, Table 157
49.
Stone HH, et al: Antibiotic prophylaxis in gastric, biliary and colonic surgery . Ann Surg184:443, 1976
50.
Shapiro M., et al: Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. JAMA249:1290, 1983
51.
Couch NP, et al: The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med304:634, 1981
52.
Couch NP, Tilney NL, Moore FD: The cost of misdaventures in colonic surgery: a model for the analysis of adverse outcomes in standard procedures. Am J Surg135:641, 1978
53.
Muller J.: Presented at Clinical Congress of American Society for Parenteral and Enteral Nutrition, Washington, DC, 1983
54.
Williams SV , et al: Improved cost allocation in case-mix accounting. Med Care20:450, 1982